Dr. Stone is going to the moon! Eventually! After season 3 revealed post-apocalyptic science prodigy Senku Ishigami's ultimate goal of traveling to the lunar surface to reverse the process that ...
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...
What the former intelligence chief will tell the inquiry commission remains the point of great public interest as many tend to suspect him as the... ISLAMABAD: While the Election Commission of ...
The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.
Dr. Will Kirby hinted at plans to move on from reality TV after season 2 of Deal or No Deal Island. “This is a young person’s game,” Dr. Will, 52, told People on Tuesday, January 14. “I ...
Among those names are Tampa Bay Buccaneers offensive coordinator Liam Coen and Detroit Lions offensive coordinator Ben Johnson, two coaches who entered the process as potential favorites for ...
Diontae Johnson has been claimed on waivers by the Baltimore Ravens one day after he parted ways with the Houston Texans, according to ESPN's Adam Schefter. Johnson joined the Texans on Dec.
Umar Nurmagomedov and Merab Dvalishvili have very different demeanors heading into their bantamweight title fight at UFC 311. Dvalishvili, the champion, was a ball of rage at December's pre-fight ...
Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...
The purchase will allow Johnson & Johnson to delve further into the treatment of central nervous system disorders. The purchase is one of several transactions in recent years to boost its ...
Johnson & Johnson (NYSE:JNJ) announced a $14.6 billion acquisition of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ahead of this week’s JP Morgan Healthcare Conference. Shares of Intra-Cellular ...